003.21 | Salmonella meningitis |
013.00–013.06 | Tuberculous meningitis |
013.40–013.46 | Tuberculoma of spinal cord |
013.50–013.56 | Tuberculous abscess of spinal cord |
013.60–013.66 | Tuberculous encephalitis or myelitis |
015.00–015.06 | Tuberculosis of vertebral column |
045.00–045.03 | Acute paralytic poliomyelitis specified as bulbar |
045.10–045.13 | Acute poliomyelitis with other paralysis |
045.20–045.23 | Acute non-paralytic poliomyelitis |
045.90–045.93 | Acute poliomyelitis, unspecified |
091.81 | Acute syphilitic meningitis (secondary) |
094.0–094.3 | Neurosyphilis |
094.81–094.87 | Other specified neurosyphilis |
094.89 | Other specified neurosyphilis, other |
094.9 | Neurosyphilis, unspecified |
098.82 | Gonococcal meningitis |
100.81 | Leptospiral meningitis (aseptic) |
112.83 | Candidal meningitis |
114.2 | Coccidioidal meningitis |
115.01 | Histoplasma capsulatum meningitis |
115.11 | Histoplasma duboisii meningitis |
130.0 | Meningoencephalitis due to toxoplasmosis |
140.0–140.1 | Malignant neoplasm of lip |
140.3–140.6 | Malignant neoplasm of lip |
140.8–140.9 | Malignant neoplasm of lip |
141.0–141.6 | Malignant neoplasm of tongue |
141.8–141.9 | Malignant neoplasm of tongue |
142.0–142.2 | Malignant neoplasm of major salivary glands |
142.8–142.9 | Malignant neoplasm of major salivary glands |
143.0–143.1 | Malignant neoplasm of gum |
143.8–143.9 | Malignant neoplasm of gum |
144.0–144.1 | Malignant neoplasm of floor of mouth |
144.8–144.9 | Malignant neoplasm of floor of mouth |
145.0–145.6 | Malignant neoplasm of other and unspecified parts of mouth |
145.8–145.9 | Malignant neoplasm of other and unspecified parts of mouth |
146.0–146.9 | Malignant neoplasm of oropharynx |
147.0–147.3 | Malignant neoplasm of nasopharynx |
147.8–147.9 | Malignant neoplasm of nasopharynx |
148.0–148.3 | Malignant neoplasm of hypopharynx |
148.8–148.9 | Malignant neoplasm of hypopharynx |
149.0–149.1 | Malignant neoplasm of other and ill-defined sites within the lip, oral cavity, and pharynx |
149.8–149.9 | Malignant neoplasm of other and ill-defined sites within the lip, oral cavity, and pharynx |
150.0–150.5 | Malignant neoplasm of esophagus |
150.8–150.9 | Malignant neoplasm of esophagus |
151.0–151.6 | Malignant neoplasm of stomach |
151.8–151.9 | Malignant neoplasm of stomach |
152.0–152.3 | Malignant neoplasm of small intestine, including duodenum |
152.8–152.9 | Malignant neoplasm of small intestine, including duodenum |
153.0–153.9 | Malignant neoplasm of colon |
154.0–154.3 | Malignant neoplasm of rectum, rectosigmoid junction, and anus |
154.8 | Malignant neoplasm of anus unspecified |
155.0–155.2 | Malignant neoplasm of liver and intrahepatic bile ducts |
156.0–156.2 | Malignant neoplasm of gallbladder and extrahepatic bile ducts |
156.8–156.9 | Malignant neoplasm of gallbladder and extrahepatic bile ducts |
157.0–157.4 | Malignant neoplasm of pancreas |
157.8–157.9 | Malignant neoplasm of pancreas |
158.0 | Malignant neoplasm of retroperitoneum |
158.8 | Malignant neoplasm of specified parts of peritoneum |
159.0–159.1 | Malignant neoplasm of other and ill-defined sites within the digestive organs and peritoneum |
159.8–159.9 | Malignant neoplasm of other and ill-defined sites within the digestive organs and peritoneum |
160.0–160.5 | Malignant neoplasm of nasal cavities, middle ear, and accessory sinuses |
160.8–160.9 | Malignant neoplasm of nasal cavities, middle ear, and accessory sinuses |
161.0–161.3 | Malignant neoplasm of larynx |
161.8–161.9 | Malignant neoplasm of larynx |
162.0 | Malignant neoplasm of trachea |
162.2–162.5 | Malignant neoplasm of trachea, bronchus, and lung |
162.8–162.9 | Malignant neoplasm of trachea, bronchus, and lung |
163.0–163.1 | Malignant neoplasm of pleura |
163.8–163.9 | Malignant neoplasm of pleura |
164.0–164.3 | Malignant neoplasm of thymus, heart, and mediastinum |
164.8–164.9 | Malignant neoplasm of thymus, heart, and mediastinum |
165.0 | Malignant neoplasm of upper respiratory tract, part unspecified |
165.8–165.9 | Malignant neoplasm of other and ill-defined sites within the respiratory system and intrathoracic organs |
170.0–170.9 | Malignant neoplasm of bone and articular cartilage |
171.0 | Malignant neoplasm of connective and other soft tissue, head, face and neck |
171.2–171.9 | Malignant neoplasm of connective and other soft tissue |
172.0–172.9 | Malignant melanoma of skin |
173.0–173.9 | Other malignant neoplasm of skin |
174.0–174.6 | Malignant neoplasm of female breast |
174.8–174.9 | Malignant neoplasm of female breast |
175.0 | Malignant neoplasm of male breast, nipple and areola |
175.9 | Malignant neoplasm of other and unspecified sites of male breast |
176.0–176.5 | Kaposi’s sarcoma |
176.8–176.9 | Kaposi’s sarcoma |
179 | Malignant neoplasm of uterus, part unspecified |
180.0–180.1 | Malignant neoplasm of cervix uteri |
180.8–180.9 | Malignant neoplasm of cervix uteri |
181 | Malignant neoplasm of placenta |
182.0–182.1 | Malignant neoplasm of body of uterus |
182.8 | Malignant neoplasm of other specified site of body of uterus |
183.0 | Malignant neoplasm of ovary |
183.2–183.5 | Malignant neoplasm of ovary and other uterine adnexa |
183.8–183.9 | Malignant neoplasm of ovary and other uterine adnexa |
184.0–184.4 | Malignant neoplasm of other and unspecified female genital organs |
184.8–184.9 | Malignant neoplasm of other and unspecified female genital organs |
185 | Malignant neoplasm of prostate |
186.0 | Malignant neoplasm of undescended testis |
186.9 | Malignant neoplasm of other and unspecified testis |
187.1–187.9 | Malignant neoplasm of penis and other male genital organs |
188.0–188.9 | Malignant neoplasm of bladder |
189.0–189.4 | Malignant neoplasm of kidney and other and unspecified urinary organs |
189.8–189.9 | Malignant neoplasm of kidney and other and unspecified urinary organs |
190.0–190.9 | Malignant neoplasm of eye |
192.1–192.3 | Malignant neoplasm of cerebral meninges, spinal cord, and spinal meninges |
193 | Malignant neoplasm of thyroid gland |
194.6 | Malignant neoplasm of aortic body and other paraganglia |
195.0–195.5 | Malignant neoplasm of other and ill-defined sites |
195.8 | Malignant neoplasm of other specified sites |
196.0–196.3 | Secondary and unspecified malignant neoplasm of lymph nodes |
196.5–196.6 | Secondary and unspecified malignant neoplasm of lymph nodes |
196.8–196.9 | Secondary and unspecified malignant neoplasm of lymph nodes |
197.0–197.8 | Secondary malignant neoplasm of respiratory and digestive systems |
198.0*–198.7* | Secondary malignant neoplasm of other specified sites |
198.81*–198.82* | Secondary malignant neoplasm of other specified sites |
198.89* | Secondary malignant neoplasm of other specified sites |
| Note: Use 198.XX range of codes to indicate metastases to the spinal column. |
199.0–199.2 | Malignant neoplasm without specification of site |
200.00–200.08 | Reticulosarcoma |
200.10–200.18 | Lymphosarcoma |
200.20–200.28 | Burkitt’s tumor or lymphoma |
200.30–200.38 | Marginal zone lymphoma |
200.40–200.48 | Mantle cell lymphoma |
200.50–200.58 | Primary central nervous system lymphoma |
200.60–200.68 | Anaplastic large cell lymphoma |
200.70–200.78 | Large cell lymphoma |
200.80–200.88 | Lymphosarcoma and reticulosarcoma, other named variants |
201.00–201.08 | Hodgkin’s paragranuloma |
201.10–201.18 | Hodgkin’s granuloma |
201.20–201.28 | Hodgkin’s sarcoma |
201.40–201.48 | Hodgkin’s disease, lymphocytic-histiocytic predominance |
201.50–201.58 | Hodgkin’s disease, nodular sclerosis |
201.60–201.68 | Hodgkin’s disease, mixed cellularity |
201.70–201.78 | Hodgkin’s disease, lymphocytic depletion |
201.90–201.98 | Hodgkin’s disease, unspecified |
202.00–202.08 | Nodular lymphoma |
202.10–202.18 | Mycosis fungoides |
202.20–202.28 | Sezary’s disease |
202.30–202.38 | Malignant histiocytosis |
202.40–202.48 | Leukemic reticuloendotheliosis |
202.50–202.58 | Letterer-Siwe disease |
202.60–202.68 | Malignant mast cell tumors |
202.70–202.78 | Peripheral T cell lymphoma |
202.80–202.88 | Other lymphomas |
202.90–202.98 | Other and unspecified malignant neoplasms of lymphoid and histocytic tissue |
203.00–203.02 | Multiple myeloma |
203.10–203.12 | Plasma cell leukemia |
203.80–203.82 | Other immunoproliferative neoplasms |
204.00–204.02 | Acute lymphoid leukemia |
204.10–204.12 | Chronic lymphoid leukemia |
204.20–204.22 | Subacute lymphoid leukemia |
204.80–204.82 | Other lymphoid leukemia |
204.90–204.92 | Unspecified lymphoid leukemia |
205.00–205.02 | Acute myeloid leukemia |
205.10–205.12 | Chronic myeloid leukemia |
205.20–205.22 | Subacute myeloid leukemia |
205.30–205.32 | Myeloid sarcoma |
205.80–205.82 | Other myeloid leukemia |
205.90–205.92 | Unspecified myeloid leukemia |
206.00–206.02 | Acute monocytic leukemia |
206.10–206.12 | Chronic monocytic leukemia |
206.20–206.22 | Subacute monocytic leukemia |
206.80–206.82 | Other monocytic leukemia |
206.90–206.92 | Unspecified monocytic leukemia |
207.00–207.02 | Acute erythremia and erythroleukemia |
207.10–207.12 | Chronic erythremia |
207.20–207.22 | Megakaryocytic leukemia |
207.80–207.82 | Other specified leukemia |
208.00–208.02 | Acute leukemia of unspecified cell type |
208.10–208.12 | Chronic leukemia of unspecified cell type |
208.20–208.22 | Subacute leukemia of unspecified cell type |
208.80–208.82 | Other leukemia of unspecified cell type |
208.90–208.92 | Unspecified leukemia of unspecified cell type |
213.2 | Benign neoplasm of vertebral column, excluding sacrum and coccyx |
213.6 | Benign neoplasm of pelvic bones, sacrum, and coccyx |
213.9 | Benign neoplasm of bone and articular cartilage, site unspecified |
215.8–215.9 | Other benign neoplasm of connective and other soft tissue |
225.3–225.4 | Benign neoplasm of brain and other parts of nervous system |
225.8–225.9 | Benign neoplasm of brain and other parts of nervous system |
227.6 | Benign neoplasm of aortic body and other paraganglia |
228.00 | Hemangioma of unspecified site |
228.09 | Hemangioma of other sites |
237.3 | Neoplasm of uncertain behavior of paraganglia |
237.5–237.6 | Neoplasm of uncertain behavior of endocrine glands and nervous system |
237.70–237.73 | Neurofibromatosis |
237.79 | Other neurofibromatosis |
237.9 | Neoplasm of uncertain behavior of other and unspecified parts of nervous system |
238.0–238.1 | Neoplasm of uncertain behavior of other and unspecified sites and tissues |
238.6 | Neoplasm of uncertain behavior of plasma cells |
238.72–238.75 | Neoplasm of uncertain behavior of other lymphatic and hematopoietic tissues |
239.2 | Neoplasm of unspecified nature of bone, soft tissue, and skin |
239.6–239.7 | Neoplasm of unspecified nature |
239.89 | Neoplasms of unspecified nature, other specified sites |
320.0–320.3 | Bacterial meningitis |
320.7 | Meningitis in other bacterial diseases classified elsewhere |
320.81–320.82 | Meningitis due to other specified bacteria |
320.89 | Meningitis due to other specified bacteria |
320.9 | Meningitis due to unspecified bacterium |
321.0–321.4 | Meningitis due to other organisms |
321.8 | Meningitis due to other non-bacterial organisms classified elsewhere |
322.0–322.2 | Meningitis of unspecified cause |
322.9 | Meningitis, unspecified |
323.01–323.02 | Encephalitis, myelitis, and encephalomyelitis in viral diseases, classified elsewhere |
323.1–323.2 | Encephalitis, myelitis, and encephalomyelitis |
323.41–323.42 | Other encephalitis, myelitis, and encephalomyelitis due to infection, classified elsewhere |
323.52 | Myelitis following immunization procedures |
323.61–323.63 | Postinfectious encephalitis, myelitis, and encephalomyelitis |
323.71–323.72 | Toxic encephalitis and encephalomyelitis – Toxic myelitis |
323.81–323.82 | Other causes of encephalitis, myelitis, and encephalomyelitis |
323.9 | Unspecified cause of encephalitis |
324.1 | Intraspinal abscess |
326* | Late effects of intracranial abscess or pyogenic infection |
| Note: Use 326 to indicate late effects of syringomyelitis. |
335.20–335.24 | Motor neuron disease |
335.29 | Other motor neuron diseases |
336.0–336.3 | Other diseases of spinal cord |
336.8*–336.9* | Other diseases of spinal cord |
| Note: Use 336.8 or 336.9 to indicate cord compression. |
340 | Multiple sclerosis |
341.0–341.1 | Other demyelinating diseases of central nervous system |
341.8–341.9 | Other demyelinating diseases of central nervous system |
343.0–343.4 | Infantile cerebral palsy |
344.00–344.04 | Other paralytic syndromes |
344.09 | Other quadriplegia |
344.60–344.61 | Other paralytic syndromes, cauda equina syndrome |
344.89 | Other specified paralytic syndrome |
349.1–349.2 | Other and unspecified disorders of the nervous system |
349.31 | Accidental puncture or laceration of dura during a procedure |
349.39 | Other dural tear |
353.1 | Lumbosacral plexus lesions |
353.4 | Lumbosacral root lesions, not elsewhere classified |
353.8 | Other nerve root and plexus disorders |
355.71 | Causalgia of lower limb |
442.89* | Aneurysm of other specified site |
| Note: Use 442.89 to indicate aneurysm of spinal artery. |
720.0 | Ankylosing spondylitis |
720.81 | Inflammatory spondylopathies in diseases classified elsewhere |
721.42 | Spondylosis with myelopathy, lumbar region |
721.91 | Spondylosis of unspecified site with myelopathy |
722.10 | Displacement of lumbar intervertebral disc without myelopathy |
722.2 | Displacement of intervertebral disc, site unspecified, without myelopathy |
722.52 | Degeneration of lumbar or lumbosacral intervertebral disc |
722.73 | Intervertebral disc disorder with myelopathy, lumbar region |
722.83 | Postlaminectomy syndrome of lumbar region |
722.93 | Other and unspecified disc disorder of lumbar region |
724.00 | Spinal stenosis, unspecified region |
724.02–724.03 | Spinal stenosis, unspecified region |
724.3–724.4 | Other and unspecified disorders of back |
730.08 | Acute osteomyelitis involving other specified sites |
730.18 | Chronic osteomyelitis involving other specified sites |
732.0 | Juvenile osteochondrosis of spine |
733.00–733.03 | Other disorders of bone and cartilage, osteoporosis |
733.09 | Other osteoporosis |
733.10–733.16 | Other disorders of bone and cartilage, pathologic fracture |
733.19 | Pathologic fracture of other specified site |
733.20–733.22 | Other disorders of bone and cartilage, cyst of bone |
733.29 | Other bone cyst |
733.3 | Hyperostosis of skull |
733.40–733.44 | Other disorders of bone and cartilage, aseptic necrosis of bone |
733.49 | Aseptic necrosis of other bone sites |
733.5–733.7 | Other disorders of bone and cartilage |
733.81–733.82 | Malunion and non-union of fracture |
733.90–733.92 | Disorder of bone and cartilage, unspecified |
733.99 | Other disorders of bone and cartilage, other |
737.0 | Adolescent postural kyphosis |
737.10–737.12 | Curvature of spine, kyphosis (acquired) |
737.19 | Other kyphosis, (acquired) (postural) |
737.20–737.22 | Curvature of spine, lordosis (acquired) |
737.29 | Other lordosis, acquired |
737.30–737.34 | Curvature of spine, kyphoscoliosis and scoliosis |
737.39 | Other kyphoscoliosis and scoliosis |
737.40–737.43 | Curvature of spine associated with other conditions |
737.8*–737.9* | Curvature of spine |
| Note: Use 737.8 or 737.9 to indicate patients with clinically significant symptoms or for pre-operative evaluation. |
738.4 | Acquired spondylolisthesis |
741.00 | Spina bifida, unspecified region, with hydrocephalus |
741.03 | Spina bifida, lumbar region, with hydrocephalus |
741.90 | Spina bifida, unspecified region, without mention of hydrocephalus |
741.93 | Spina bifida, lumbar region, without mention of hydrocephalus |
742.51 | Diastematomyelia |
742.53 | Hydromyelia |
742.59 | Other specified congenital anomalies of spinal cord |
742.9 | Unspecified congenital anomaly of brain, spinal cord, and nervous system |
747.82 | Spinal vessel anomaly |
754.2 | Congenital musculoskeletal deformities of spine |
756.11–756.12 | Anomalies of spine |
756.17 | Spina bifida occulta |
756.4 | Chondrodystrophy |
767.4 | Injury to spine and spinal cord due to birth trauma |
781.2 | Abnormality of gait |
781.4 | Transient paralysis of limb |
782.0 | Symptom, disturbance of skin sensation |
793.7* | Non-specific (abnormal) findings on radiological and other examination of musculoskeletal system |
| Note: Use 793.7 to indicate an abnormal bone scan. |
793.91 | Image test inconclusive due to excess body fat |
793.99 | Other nonspecific (abnormal) findings on radiological and other examination of body structure |
805.4–805.9 | Closed fracture of lumbar vertebra without mention of spinal cord injury |
806.4–806.5 | Fracture of lumbar spine with spinal cord injury |
806.60–806.62 | Fracture of vertebral column with spinal cord injury, sacrum and coccyx, closed |
806.69 | Closed fracture of sacrum and coccyx with other spinal cord injury |
806.70–806.72 | Fracture of vertebral column with spinal cord injury, sacrum and coccyx, open |
806.79 | Open fracture of sacrum and coccyx with other spinal cord injury |
839.20 | Closed dislocation, lumbar vertebra |
839.30 | Open dislocation, lumbar vertebra |
839.41–839.42 | Other multiple and ill-defined dislocations, other vertebra, closed |
839.49 | Closed dislocation, other vertebra, other |
839.51–839.52 | Other multiple and ill-defined dislocations, other vertebra, open |
839.59 | Open dislocation, other vertebra, other |
909.2 | Late effect of radiation |
926.11 | Crushing injury of back |
952.2–952.4 | Spinal cord injury without evidence of spinal bone injury |
952.8–952.9 | Spinal cord injury without evidence of spinal bone injury |
953.2–953.3 | Injury to nerve roots and spinal plexus |
